3,3'-diindolylmethane has been researched along with Bone Cancer in 3 studies
3,3'-diindolylmethane: anti-inflammatory from edible cruciferous vegetables; a cytochrome P-450 antagonist
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (66.67) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Rahman, KM | 1 |
| Banerjee, S | 2 |
| Ali, S | 2 |
| Ahmad, A | 2 |
| Wang, Z | 2 |
| Kong, D | 2 |
| Sakr, WA | 1 |
| Li, Y | 2 |
| Bao, B | 1 |
| Sarkar, FH | 2 |
| Bhuiyan, MM | 1 |
| Ahmed, F | 1 |
3 other studies available for 3,3'-diindolylmethane and Bone Cancer
| Article | Year |
|---|---|
3,3'-Diindolylmethane enhances taxotere-induced apoptosis in hormone-refractory prostate cancer cells through survivin down-regulation.
Topics: Animals; Antineoplastic Agents; Apoptosis; Bone Neoplasms; Breast Neoplasms; Cell Division; Cell Lin | 2009 |
Targeting bone remodeling by isoflavone and 3,3'-diindolylmethane in the context of prostate cancer bone metastasis.
Topics: Bone Neoplasms; Bone Remodeling; Cadherins; Cell Differentiation; Cell Line, Tumor; Coculture Techni | 2012 |
Down-regulation of androgen receptor by 3,3'-diindolylmethane contributes to inhibition of cell proliferation and induction of apoptosis in both hormone-sensitive LNCaP and insensitive C4-2B prostate cancer cells.
Topics: Androgen Receptor Antagonists; Anticarcinogenic Agents; Apoptosis; Bone Neoplasms; Cell Growth Proce | 2006 |